Pregled bibliografske jedinice broj: 196245
Sterolides-a new class of potent anti-inflammatory compounds
Sterolides-a new class of potent anti-inflammatory compounds // The Inflammation Research Association, 12th International Conference - Abstracts. in: Inflammation Research. 53(Suppl 3):S, 2004
New York City (NY), Sjedinjene Američke Države, 2004. str. 227-227 (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 196245 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Sterolides-a new class of potent anti-inflammatory compounds
Autori
Merćep, Mladen ; Tomašković, Linda ; Hrvačić, Boška ; Marković, Stribor ; Makaruha Stegić, Oresta ; Poljak, Višnja ; Komac, Marijana ; Šijan, Gordana ; Selmani, Selvira ; Ragač, Biserka ; Pešut, Anica ; Horvatinčić, Milka ; Bošnjak, Berislav ; Matijašić, Mario ; Vrančić, Mila ; Gjuračić, Krešimir ; Stanić, Barbara ; Stipaničić, Siniša ; Marković, Darko ; Ferenčić, Željko ; Mesić, Milan
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The Inflammation Research Association, 12th International Conference - Abstracts. in: Inflammation Research. 53(Suppl 3):S, 2004
/ - , 2004, 227-227
Skup
The Inflammation Research Association, 12th International Conference
Mjesto i datum
New York City (NY), Sjedinjene Američke Države, 03.10.2004. - 07.10.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
sterolides; antiinflammatory; asthma
Sažetak
Steroids are the most potent anti-inflammatory drugs and are a mainstay of asthma therapy. However, their use is associated with a number of unwanted side activities like growth retardation, suppression of hypothalamic-pituitary-adrenal axis (HPA), osteoporosis etc. Several strategies have been employed in development of anti-inflammatory steroids with reduced systemic side effects. Two main approaches have been: 1) increase of corticosteroids lipophilicity by esterifying the steroid hydroxyl groups, and 2) incorporation of metabolically labile functional groups at various positions of corticosteroids which undergo a predictable biotransformation to inactive metabolites upon entry into systemic circulation ("antedrug" or "soft" drug concept). We used a novel "sterolide" concept (steroid-macrolide conjugates) where we combined property of macrolides to preferentially accumulate in immune cells, especially in phagocyte cells (peripheral blood mononuclear cells, peritoneal and alveolar macrophages) with potent anti-inflammatory activity of classic steroids. These molecules accumulate in macrophage cell line Raw264.7 and lymphoid cell line Jurkat in vitro with greatly prolonged efflux time. Such sterolide molecules show excellent anti-inflammatory activity in several animal models with little or no systemic effects otherwise seen with standard steroids. Lead molecule is currently in the late preclinical development stage.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Ustanove:
Pliva-Istraživački institut
Profili:
Linda Tomašković
(autor)
Boška Hrvačić
(autor)
Darko Marković
(autor)
Milan Mesić
(autor)
Mario Matijašić
(autor)
Krešimir Gjuračić
(autor)
Mladen Merćep
(autor)
Željko Ferenčić
(autor)